• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

意大利的 COVID-19 大流行与肺动脉高压：适应、结果和宝贵经验教训。

The COVID-19 pandemic and pulmonary arterial hypertension in Italy: adaptation, outcomes and valuable lessons learned.

机构信息

Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

出版信息

Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.00796-2022. Print 2022 Oct.

DOI:10.1183/13993003.00796-2022
PMID:36202406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9924355/
Abstract

This editorial summarises the key findings of R. Badagliacca and co-workers regarding the changes in care and clinical outcomes of PAH patients during the initial COVID-19 pandemic in Italy https://bit.ly/3ytgIjk

摘要

这篇社论总结了 R. Badagliacca 及其同事关于意大利 COVID-19 大流行初期肺动脉高压（PAH）患者护理和临床结局变化的主要发现https://bit.ly/3ytgIjk

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ec/9924355/67710eeb0448/nihms-1869302-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ec/9924355/67710eeb0448/nihms-1869302-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ec/9924355/67710eeb0448/nihms-1869302-f0001.jpg

相似文献

1
The COVID-19 pandemic and pulmonary arterial hypertension in Italy: adaptation, outcomes and valuable lessons learned.意大利的 COVID-19 大流行与肺动脉高压：适应、结果和宝贵经验教训。
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.00796-2022. Print 2022 Oct.
2
Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.肺动脉高压与 COVID-19：拼拼凑凑。
Respir Med Res. 2023 Nov;84:101053. doi: 10.1016/j.resmer.2023.101053. Epub 2023 Oct 8.
3
Effects of COVID-19 pandemic on the management of pulmonary hypertension.新型冠状病毒肺炎大流行对肺动脉高压管理的影响。
Respir Med. 2023 Jan;206:107061. doi: 10.1016/j.rmed.2022.107061. Epub 2022 Nov 26.
4
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?意大利在 COVID-19 时代的肺动脉高压悖论：疾病进展的风险就在眼前吗？
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02276-2021. Print 2022 Oct.
5
Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the Pulmonary Vascular Research Institute.用正确的名称称呼它——肺动脉高压而非动脉性肺动脉高压：对一种广为人知的疾病的全球健康影响以及肺血管研究所的作用的认识不断提高。
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L992-L994. doi: 10.1152/ajplung.00098.2020. Epub 2020 Apr 1.
6
Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.在 COVID-19 大流行和远程医疗革命时代的肺动脉高压患者的风险评估：最新综述。
J Heart Lung Transplant. 2021 Mar;40(3):172-182. doi: 10.1016/j.healun.2020.12.005. Epub 2020 Dec 19.
7
Patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension during the COVID-19 pandemic (2020-2022): clinical outcomes, prognostic factors, and response to vaccination.2019冠状病毒病大流行期间（2020 - 2022年）的肺动脉高压和慢性血栓栓塞性肺动脉高压患者：临床结局、预后因素及疫苗接种反应
Pol Arch Intern Med. 2024 Mar 27;134(3). doi: 10.20452/pamw.16706. Epub 2024 Mar 19.
8
Pulmonary arterial hypertension registries: past, present and into the future.肺动脉高压登记研究：过去、现在和未来。
Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0128-2019. Print 2019 Dec 31.
9
Surgery in phase 3 of the COVID-19 pandemic in Northern Italy spoke hospitals. Comments to "reply to letter to the editor: Surgery in the COVID-19 phase 2 Italian scenario: Lessons learned in Northern Italy spoke hospitals".意大利北部新冠疫情第三阶段的外科手术——来自各家医院的评论。对《致编辑的信的回复：新冠疫情第二阶段意大利的外科手术：意大利北部各家医院的经验教训》的评论
J Trauma Acute Care Surg. 2021 Feb 1;90(2):e60. doi: 10.1097/TA.0000000000003023.
10
[Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future].[肺动脉高压：现代治疗的成就与现状，展望未来]
Ter Arkh. 2021 Sep 15;93(9):1009-1017. doi: 10.26442/00403660.2021.09.201013.

引用本文的文献

1
Clinical use of macitentan in the treatment of connective tissue disease-associated pulmonary arterial hypertension.马昔腾坦在治疗结缔组织病相关肺动脉高压中的临床应用。
J Thorac Dis. 2024 Mar 29;16(3):2060-2069. doi: 10.21037/jtd-24-151. Epub 2024 Mar 27.
2
COVID-19 vaccination for children with pulmonary hypertension: efficacy, safety and reasons for opting against vaccination.肺动脉高压患儿的 COVID-19 疫苗接种：有效性、安全性及拒绝接种的原因
Front Pediatr. 2023 Oct 4;11:1259753. doi: 10.3389/fped.2023.1259753. eCollection 2023.

本文引用的文献

1
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?意大利在 COVID-19 时代的肺动脉高压悖论：疾病进展的风险就在眼前吗？
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02276-2021. Print 2022 Oct.
2
Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors.新冠病毒疾病康复者的肺动脉高压和右心室收缩功能障碍
Cardiol J. 2022;29(1):163-165. doi: 10.5603/CJ.a2021.0159. Epub 2021 Dec 13.
3
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
SARS-CoV-2 感染对肺血管的潜在长期影响：全球视角。
Nat Rev Cardiol. 2022 May;19(5):314-331. doi: 10.1038/s41569-021-00640-2. Epub 2021 Dec 6.
4
Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE).肺动脉高压和慢性血栓栓塞性肺动脉高压患者中新型冠状病毒肺炎的发病率及预后：来自希腊肺动脉高压注册研究（HOPE）的数据
Hellenic J Cardiol. 2022 Mar-Apr;64:93-96. doi: 10.1016/j.hjc.2021.10.002. Epub 2021 Nov 26.
5
Factors Influencing the Evolution of Pulmonary Hypertension in Previously Healthy Subjects Recovering from a SARS-CoV-2 Infection.影响从新冠病毒感染中康复的既往健康受试者肺动脉高压演变的因素
J Clin Med. 2021 Nov 12;10(22):5272. doi: 10.3390/jcm10225272.
6
Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic.疫情期间肺动脉高压和慢性血栓栓塞性肺动脉高压患者对新冠病毒的恐惧、焦虑和抑郁
J Clin Med. 2021 Sep 16;10(18):4195. doi: 10.3390/jcm10184195.
7
Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis.COVID-19 住院患者右心功能障碍的患病率及其对全因死亡的影响：系统评价和荟萃分析。
Sci Rep. 2021 Sep 7;11(1):17774. doi: 10.1038/s41598-021-96955-8.
8
Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care.急性肺动脉高压与重症 COVID-19 患者需接受重症监护的短期结局。
Acta Anaesthesiol Scand. 2021 Jul;65(6):761-769. doi: 10.1111/aas.13819. Epub 2021 Mar 27.
9
COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?2019冠状病毒病的经历与肺动脉高压：早期观点与新数据是否仍然相符？
Ann Am Thorac Soc. 2021 Jun;18(6):1080-1081. doi: 10.1513/AnnalsATS.202012-1498LE.
10
Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS).急性呼吸窘迫综合征（ARDS）中肺动脉高压的机制
Front Mol Biosci. 2021 Jan 18;7:624093. doi: 10.3389/fmolb.2020.624093. eCollection 2020.